Qantas expects international unit to be twice as profitable as tourism rebounds

<html xmlns=""><head><title>UPDATE 1-Qantas expects international unit to be twice as profitable as tourism rebounds</title></head><body>

Rewrites through to focus on earnings forecast from long-haul flights, adds margins growth outlook in paragraph 2, adds outgoing CEO comment in paragraph 3, adds share movement in paragraph 7

May 30 (Reuters) -Qantas Airways QAN.AX on Tuesday forecast its international divisions to be twice as profitable in the post-COVID era on strong recovery in tourism, with earnings at domestic and loyalty divisions also projected to improve.

International margins at Australia's flagship carrier are forecast to grow to more than 8% in fiscal 2024, with its long-haul travel program Project Sunrise set to take off in late 2025, seen further boosting margins up to 12% in the future.

"This is a structurally different business than it was before COVID, operating in markets that have also changed," Alan Joyce, Qantas' outgoing chief executive officer said.

Project Sunrise, which will start with Sydney to London and New York on Airbus A350-1000 aircraft, is projected to deliver earnings in excess of around A$400 million ($261 million) every year from when all 12 aircraft ordered complete their first full year in service.

Qantas also expects its Loyalty division to reach its fiscal 2024 earnings before interest and taxes target of A$500 -A$600 million, rising further to A$800 million to A$1 billion by fiscal 2030.

Qantas reaffirmed its 2024 capital expenditure forecast provided in February of between A$3 billion and A$3.2 billion. That compares with its fiscal 2023 outlook of A$2.6 billion to A$2.7 billion.

Qantas shares were trading 1.8% higher as at 0300 GMT, marking their biggest intraday gain in nearly a week.

($1 = 1.5334 Australian dollars)

Reporting by Sameer Manekar and Navya Mittal in Bengaluru; Editing by Shailesh Kuber


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.